Biosimilars: it's not as simple as cost alone.
Background: Biosimilars or follow-on biologics (FoB) are biopharmaceuticals that, unlike small molecule generic products, are copies of larger, much more complex proteins. As such, data generated from one biopharmaceutical cannot be extrapolated to another. Unlike small molecule generics, FoB requir...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 33; no. 5; pp. 459 - 465 |
|---|---|
| Autores principales: | , |
| Formato: | tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Oct2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |